NDAORALTABLET
Approved
Sep 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 19h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Vicoprofen is a fixed-dose combination of hydrocodone bitartrate (opioid analgesic) and ibuprofen (NSAID) in oral tablet form, approved in 1997. It is indicated for short-term management of acute pain where the severity of pain requires opioid treatment. The combination leverages synergistic analgesic effects: hydrocodone provides opioid analgesia while ibuprofen adds anti-inflammatory and additional analgesic benefits.
LOE Approaching
The product is in late-stage lifecycle with moderate competitive pressure (30/100), suggesting a defensive positioning phase where teams focus on retention and compliance rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Vicoprofen offers limited growth opportunity given its LOE-approaching lifecycle and minimal linked job count (0). Roles available are primarily in legacy product management, compliance, and field maintenance rather than innovation-driven career advancement.
Brand ManagerField Sales Representative
Worked on VICOPROFEN at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.